Clinical Trials Browser

Phase EARLY_PHASE1 × Lymphoid × Clear all

NCT03422731 2026-04-15

Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy

Phase EARLY_PHASE1 Recruiting

LymphoidOther hematologic neoplasm

Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06986434 2026-04-08

CAR19BCMA CAR-T Cells for the Treatment of R/R Plasma Cell Neoplasms and Lymphomas/Leukemias With Plasmacytic Differentiation

Phase EARLY_PHASE1 Not yet recruiting

LymphoidPlasma cell

Lymphoma, Recurrence, Neoplasms, Plasma Cell

NCT07376642 2026-03-30

A Phase I/IIa, Open-label, Single-center, Dose-escalation and Dose-expansion Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of IMV101 as a Single Agent in Subjects With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

Phase EARLY_PHASE1 Recruiting

Lymphoma, B-Cell

NCT07476027 2026-03-17

Efficacy and Safety of CD7 CAR-T in Newly Diagnosed High-Risk T-LBL/ALL

Phase EARLY_PHASE1 Not yet recruiting

LymphoidOther hematologic neoplasm

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT05294367 2026-03-16

Dietary and Topical Magnesium Replacement or Supplementation in Patients With Lymphoma

Phase EARLY_PHASE1 Recruiting

Lymphoma

NCT07428707 2026-03-13

Immune Profiling of CLL/SLL Treated With First-Line Pirtobrutinib

Phase EARLY_PHASE1 Recruiting

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

NCT05495464 2026-02-27

A Pilot "Window-3" Study of Acalabrutinib Plus Rituximab Followed by Brexucabtagene Autoleucel Therapy in Patients With Previously Untreated High-risk Mantle Cell Lymphoma

Phase EARLY_PHASE1 Active not recruiting

Lymphoma, Lymphoma, Mantle-Cell

NCT06235281 2026-02-27

PLIGHT

Phase EARLY_PHASE1 Suspended

Mycosis Fungoides

NCT07429461 2026-02-24

Clinical Study of SYNCAR-100 in the Treatment of Relapsed/Refractory Acute B-Lymphoblastic Leukemia

Phase EARLY_PHASE1 Recruiting

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Leukemia

NCT03445858 2026-02-18

Pembrolizumab in Combination With Decitabine and Hypofractionated Index Lesion Radiation in Pediatrics and Young Adults

Phase EARLY_PHASE1 Completed

Lymphoma, Neoplasms, Recurrence

NCT04512716 2026-02-17

Iomab-ACT: A Pilot Study of 131-I Apamistamab Followed by CD19-Targeted CAR T-Cell Therapy for Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia or Diffuse Large B-Cell Lymphoma

Phase EARLY_PHASE1 Recruiting

Lymphoma, Large B-Cell, Diffuse, Pyloric Stenosis, Hypertrophic

NCT05093335 2026-02-05

In-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PET

Phase EARLY_PHASE1 Recruiting

LymphoidMyeloidPlasma cell

Lymphoma, Non-Hodgkin, Multiple Myeloma, Histiocytosis, Sinus, Erdheim-Chester Disease

NCT05800405 2026-02-04

Evaluation of Bridging Radiation Therapy Before CAR T-Cell Infusion for the Treatment of Relapsed or Refractory Large B-Cell Lymphoma

Phase EARLY_PHASE1 Recruiting

Lymphoma, Large B-Cell, Diffuse

NCT04161248 2026-02-02

Phase I Master Protocol of Novel Combination Therapy for Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma

Phase EARLY_PHASE1 Recruiting

Lymphoma, B-Cell

NCT05921253 2026-01-26

OU-SCC-NCAN

Phase EARLY_PHASE1 Recruiting

Breast Neoplasms, Lymphoma

NCT06662227 2026-01-20

Universal CAR-T Cells (REVO-UWD-19) for Refractory and Relapsed B-Cell Tumors

Phase EARLY_PHASE1 Recruiting

LymphoidOther hematologic neoplasm

Leukemia, B-Cell, Lymphoma, B-Cell

NCT07349849 2026-01-20

Exploratory Study on mRNA Therapeutic Drug Targeting CD19 for the Treatment of Hematologic Malignancies

Phase EARLY_PHASE1 Recruiting

B-cell Malignancies

NCT01269593 2026-01-15

PET Imaging of Cancer Patients Using 124I-PUH71: A Pilot Study

Phase EARLY_PHASE1 Active not recruiting

LymphoidPlasma cell

Lymphoma, Non-Hodgkin, Neoplasms, Plasma Cell

NCT06765876 2026-01-12

UHKT-CAR123-01

Phase EARLY_PHASE1 Recruiting

LymphoidMyeloidOther hematologic neoplasm

Blastic Plasmacytoid Dendritic Cell Neoplasm, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07335094 2026-01-12

A Clinical Study of Humanized CD19 CAR-T Cells With TLR2 for the Treatment of Adult Patients With Naive B-Cell Acute Lymphoblastic Leukemia/Lymphoma Who Are Intolerant to Intensive Chemotherapy

Phase EARLY_PHASE1 Not yet recruiting

Lymphoma

NCT04514029 2026-01-08

Neurotoxicity Prophylaxis With Intrathecal Dexamethasone and Simvastatin Post Axi-Cel

Phase EARLY_PHASE1 Active not recruiting

Lymphoma, Neurotoxicity Syndromes

NCT06514768 2026-01-06

JY231 (JY231) Injection for the Treatment of B-cell Acute Lymphoblastic Leukemia (B-ALL)

Phase EARLY_PHASE1 Recruiting

Burkitt Lymphoma

NCT07312630 2025-12-31

Clinical Study of LV009 Injection for the Treatment of Relapsed/Refractory CD19-Positive Hematologic and Lymphoid Malignancies

Phase EARLY_PHASE1 Recruiting

LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07205315 2025-12-26

A Clinical Study Evaluating the Safety and Efficacy of GT801 Injection in Adult Patients With Relapsed/Refractory CD19-positive B-cell Hematologic Malignancies and Autoimmune Hemolytic Anemia

Phase EARLY_PHASE1 Recruiting

Classical hematologyLymphoidOther hematologic neoplasm

Anemia, Hemolytic, Autoimmune, Burkitt Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell

NCT07277504 2025-12-11

Autologous Bedside CD19 CAR T-cell Therapy for B-ALL

Phase EARLY_PHASE1 Not yet recruiting

Burkitt Lymphoma

NCT07162012 2025-12-02

Anti-EBV TCR-T

Phase EARLY_PHASE1 Recruiting

Lymphoma, T-Cell, Peripheral, Lymphoma, Extranodal NK-T-Cell

NCT07256353 2025-12-01

Allogeneic UCB-derived CAR-T for B-ALL

Phase EARLY_PHASE1 Not yet recruiting

Burkitt Lymphoma

NCT06735690 2025-11-12

Allogeneic CMV-Specific CD19-CAR T Cells Plus CMV-MVA Triplex Vaccine After Matched Related Donor Hematopoietic Cell Transplant for the Treatment of Patients With High-Risk Acute Lymphoblastic Leukemia

Phase EARLY_PHASE1 Recruiting

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01760226 2025-10-14

DA-EPOCH-R

Phase EARLY_PHASE1 Completed

Lymphoma, Large B-Cell, Diffuse

NCT07213882 2025-10-09

CITY

Phase EARLY_PHASE1 Not yet recruiting

DermatologicLymphoid

Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous

NCT07196111 2025-09-29

BAFFR CAR-T Treatment for Relapsed/Refractory B-cell Tumors

Phase EARLY_PHASE1 Not yet recruiting

Burkitt Lymphoma, Lymphoma

NCT07197021 2025-09-29

Transcatheter Edge-to-Edge Repair In Moderate and Exertional-Induced Severe MR (TIMER)

Phase EARLY_PHASE1 Not yet recruiting

Lymphoma, Follicular

NCT06398457 2025-09-26

Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies

Phase EARLY_PHASE1 Recruiting

Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Aplastic, Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Primary Myelofibrosis

NCT06120166 2025-09-19

Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of r/r DLBCL Clinical Research

Phase EARLY_PHASE1 Recruiting

Lymphoma, Large B-Cell, Diffuse

NCT07168291 2025-09-17

Novel Bispecific AbTCR (Anti-CD19/CD22)-T Cells in Relapsed or Refractory B-cell Lymphoma

Phase EARLY_PHASE1 Not yet recruiting

Burkitt Lymphoma, Lymphoma, Follicular, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT07101705 2025-09-09

An Open-label, Single-arm Clinical Study to Evaluate the Safety and Preliminary Efficacy of OriV508 Injection in Treating Relapsed/Refractory Hematological Malignancies

Phase EARLY_PHASE1 Recruiting

LymphoidPlasma cell

Lymphoma, Non-Hodgkin, Multiple Myeloma

NCT06446128 2025-08-21

A Dose Escalating Study of CD19/CD22/BCMA CAR-T Therapy in Relapsed or Refractory B Cell Non-Hodgkin Lymphoma(NHL)

Phase EARLY_PHASE1 Recruiting

Lymphoma, Non-Hodgkin, Lymphoma, B-Cell

NCT05779930 2025-08-15

Safety and Feasibility of CD19 CAR T Cells Using CliniMACS Prodigy for Relapsed/Refractory CD19 Positive ALL and NHL

Phase EARLY_PHASE1 Not yet recruiting

LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Recurrence, Leukemia, B-Cell, Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03719105 2025-08-08

Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma

Phase EARLY_PHASE1 Recruiting

LymphoidOther hematologic neoplasm

Lymphoma, T-Cell, Peripheral, Leukemia, Large Granular Lymphocytic

NCT03957915 2025-08-06

INA03

Phase EARLY_PHASE1 Completed

LymphoidOther hematologic neoplasm

Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06636175 2025-07-31

64Cu-LLP2A for Imaging Hematologic Malignancies

Phase EARLY_PHASE1 Recruiting

LymphoidOther hematologic neoplasmPlasma cell

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Marginal Zone

NCT05049785 2025-07-25

Nutrition and Physical Activity Intervention in Preventing Excess Weight Gain in Pediatric Patients With Leukemia or Lymphoma Treated With Prednisone and/or Dexamethasone

Phase EARLY_PHASE1 Completed

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma

NCT06976437 2025-07-10

A Clinical Study of Allogeneic CD19/BCMA CAR-T Cells for the Treatment of R/R B-cell Malignant Tumors

Phase EARLY_PHASE1 Recruiting

LymphoidPlasma cell

Multiple Myeloma, Lymphoma, B-Cell

NCT07048353 2025-07-02

CAR-T，MTD

Phase EARLY_PHASE1 Not yet recruiting

Lymphoma, Lymphoma, B-Cell

NCT04139304 2025-06-29

A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma

Phase EARLY_PHASE1 Recruiting

Plasmablastic Lymphoma

NCT05386576 2025-06-15

A Study of Venetoclax in Combination With Chemotherapy to Treat Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)

Phase EARLY_PHASE1 Active not recruiting

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07003178 2025-06-04

A Study to Evaluate the Safety and Clinical Efficacy of STR-P004

Phase EARLY_PHASE1 Not yet recruiting

Lymphoma, Non-Hodgkin

NCT04034446 2025-06-03

CD19-CD22 Chimeric Antigen Receptor T (CAR-T) Cell for Treatment of B Cell Acute Lymphoblastic Leukemia (B-ALL)

Phase EARLY_PHASE1 Terminated

Burkitt Lymphoma, Recurrence

NCT06092047 2025-05-16

UTAA09 Injection in the Treatment of Relapsed/Refractory Hematolymphatic Malignancies.

Phase EARLY_PHASE1 Recruiting

CD19-positive Relapsed or Refractory B-cell Malignancies

NCT06849401 2025-05-15

The Safety and Efficacy of VGO-Cs01p in Patients With CD7-positive Relapsed/Refractory Acute T-lymphoblastic Leukemia

Phase EARLY_PHASE1 Not yet recruiting

LymphoidOther hematologic neoplasm

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma